WO2004110972A1 - (2r)−2−プロピルオクタン酸の製造方法、その中間体 - Google Patents
(2r)−2−プロピルオクタン酸の製造方法、その中間体 Download PDFInfo
- Publication number
- WO2004110972A1 WO2004110972A1 PCT/JP2004/008387 JP2004008387W WO2004110972A1 WO 2004110972 A1 WO2004110972 A1 WO 2004110972A1 JP 2004008387 W JP2004008387 W JP 2004008387W WO 2004110972 A1 WO2004110972 A1 WO 2004110972A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reaction
- acid
- group
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Definitions
- the present invention relates to a method for producing (2R) -2-propyloctanoic acid, which is useful as an agent for preventing and treating neurodegenerative diseases caused by dysfunction of astrocytes, an intermediate for producing the same, and a method for purifying the same.
- Racemic 2-propyloctanoic acid is known as a prophylactic and therapeutic agent for neurodegenerative diseases due to astrocyte dysfunction (see, for example, W099 / 58513). Subsequent research has revealed that the R-form 2-propyloctanoic acid has a particularly strong activity, and various studies have been conducted on methods for efficiently obtaining the R-form.
- Examples of the method for producing (2R) -2-propyloctanoic acid include (1) a method using camphorsultam as an asymmetric auxiliary group, (2) a method using L-prolinol as an asymmetric auxiliary group, (3) A method is known in which racemic 2- (2-probyl) octanoic acid is optically resolved and then reduced (EP-A-1078921, JP-A-8-295648, JP-A-8-295). -291106).
- an object of the present invention is to provide a production method suitable for industrial production, which can efficiently obtain (2R) -2-propyloctanoic acid with a smaller number of steps than before and without a dangerous reaction. To provide.
- the present inventors have conducted intensive studies and found that, through (2R) -2-hexyloxylan, via (2R) -2-propyloctanamide, which is excellent in crystallinity and excellent in purification in three steps.
- (2R) -2-propyloctaneamide, (IS) -1-propylheptyl p-toluenesulfonate which is an intermediate compound useful in the method for producing (2R) -2-propyloctanoic acid of the present invention.
- 1- and (1S)-1-propylheptyl 4-methansulfonate are new compounds.
- the compound of formula (I) is obtained by subjecting (2R) —2-hexyloxysilane to a two-carbon carbocyclic ring-opening reaction and then subjecting a hydroxyl group to a protection reaction.
- (2 S) —2—Hexyloxysilane is subjected to a two-carbon carbon-opening reaction to give 7 Then, the hydroxyl group is converted to a compound represented by the formula ( ⁇ ) by subjecting it to a protection reaction, and further subjected to a one-carbon enrichment reaction to convert it to (2S) -2-propyloctaneamide.
- high purity means that both chemical purity and optical purity are high.
- substantially pure means that the chemical purity is 95% or more and the optical purity is 95% ee or more.
- the “optionally protected hydroxyl group” represented by X means “a hydroxyl group protected by a protective group having an elimination ability”.
- the "hydroxyl group protected with a protective group having an elimination ability” include, for example, a methanesulfoyloxy group, a -toluenesulfonyloxy group, a chloromethanesulfuroxy group, a trichloromethanesulfonyloxy group, Trifluoromethanesulfonyloxy group, diphenylphosphonoxy group, getylphosphonoxy group, trifluoromethyloxy group, benzenesulfo-loxy group, naphthalenes-norhenoloxy group, ⁇ -promobenzens-levoninoleoxy group, A benzenesnolephoenoleoxy group, a m-mouth benzenes-no
- Step (A) is a conversion reaction of the compound represented by formula (I) by subjecting (2R) -2-hexyloxysilane to a two-carbon-carbon-opening reaction and then subjecting a hydroxyl group to a protection reaction.
- Step (B) is a conversion reaction to (2R) -2-propylotatanamide by subjecting the compound represented by the formula (I) to a one-carbon enrichment reaction and then hydrolyzing the compound.
- (C) is a reaction of hydrolyzing (2R) -2-propyloctanamide to obtain (2R) -2-propyloctanoic acid.
- the exchange reaction is carried out by subjecting (2R) -2-hexyloxysilane to a two-carbon carbocyclic ring opening reaction and then subjecting a hydroxyl group to a protection reaction.
- This two-carbon-carbon ring-opening reaction is known, and examples thereof include organic solvents (for example, tetrahydrofuran, 2-methynoletetrahydrofuran, 1,4-dioxane, diethylazethenol, cyclopentynolemethynol ether, —Methoxyxeti / ether, benzene, toluene, dimethoxetane, hexane, heptane, cyclohexane, dichloromethane, chlorophonolem, dichloroethane, hexamethylphosphoramide, dimethylimidazolidinone, N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, dimethylsulfoxide, 1,3-dimethyl-3,4,5,6-tetrahydro-2-pyrimidinone, or a mixed solvent of any combination of two or more of these
- Hydroxy group protection reactions include, for example, organic solvents (eg, tetrahydrofuran, 2-methinoletetrahydrofuran, 1,4-dioxane, ethinoleatenole, cyclopentinolemethinoleatenole, 2-methoxetino) Liethenole, benzene, tonolene, dimethoxetane, hexane, heptane, cyclohexane, dichloromethane, chlorohonolem, dichloroethane, hexametinolefos Holamide, dimethylimidazolidinone, N, N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, dimethylsulfoxide, 1,3-dimethyl-3,4,5,6-tetrahydro-2- Pyrimidinone, a mixed solvent of any ratio thereof, or the like, or in
- the (2R) -2-hexyloxysilane is subjected to a two-carbon carburization ring-opening reaction, and then the hydroxyl group is subjected to a protection reaction.
- the conversion reaction to the compound represented by the formula (I) is an intermediate (4S) -Decan-1-ol may be subjected to a one-step (one-pot) reaction in which the hydroxyl group is protected in the reaction system without isolation, or the intermediate is isolated and the hydroxyl group is protected. It may be performed in two stages, but is preferably performed in one stage (one pot).
- the method of performing step (A) in a one-pot method is to subject (2R) -2-hexyloxylan to a two-carbon enrichment ring-opening reaction, and then to form (4S) -decane-1-4-
- the isolation is carried out by subjecting the hydroxyl group to a protection reaction without isolation. That is,
- (2R) --2-Hexyloxysilane is reacted with an organometallic reagent having an ethyl group in an organic solvent in the presence or absence of a metal catalyst at a temperature of 178 ° C at 20 ° C.
- Perform protection reaction The hydroxyl group protection reaction is carried out by adding a sulfouric acid-based phosphoride, a phosphoryl-based acid-based chloride or an acid anhydride to the reaction mixture in the presence or absence of a base, and reacting the mixture at 178 to 50 ° C.
- step (A) In the conversion reaction of (2R) —2-hexyloxysilane into (4S) —decane-1-ol by a two-carbon carbon ring opening reaction in step (A), it is preferable to use tetrahydrofuran as an organic solvent. Further, it is preferable to use ethethylmagnesium chloride as an organometallic reagent together with copper chloride which is a metal catalyst.
- (1S) -1-propylheptyl: p-toluenesulfonate and (1S) -1-propylheptyl methanesulfonate are preferred.
- step (A) (4S) —decane 4-all is converted into the formula (I)!
- (I) Representing a toluenesulfuroxy group (is) —
- p-toluenesulfuryl chloride is used as a sulfoyl chloride without using an organic solvent (without solvent). It is preferable to use chloride and pyridine as the base.
- step (A) in the conversion reaction of (4S) -decane-1-ol to (1S)-1-propylheptylmethanesulfonate where X in the formula (I) represents a methanesulfonyloxy group, It is preferable to use tetrahydrofuran as the organic solvent, methanesulfuric chloride as the sulfonyl chloride, and to use triethylamine and 4-dimethylaminopyridine in combination as the base.
- step (A) From the compound of formula (I) obtained in step (A), The conversion reaction to pyroctanamide is carried out by subjecting the compound represented by the formula (I) to a one-carbon enrichment reaction, and then hydrolyzing it.
- Cyanation reactions are known and include, for example, organic solvents (eg, tetrahydrofuran, 2-methoxethyl ether, dimethoxyethane, acetonitrile, 1,4-dioxane, acetone, hexamethylphosphoramide, dimethylimidazolidyte) Non, ⁇ , ⁇ -dimethylformamide, ⁇ , ⁇ -dimethylacetamide, ⁇ -methylpyrrolidone, dimethylsulfoxide, 1,3-dimethyl-1,3,4,5,6-tetrahydro-2-pyrimidinone, or a mixture thereof , A cyanide reagent (eg, potassium cyanide, sodium cyanide, lithium cyanide, calcium cyanide, trimethylsilyl cyanide, getyl aluminum cyanide, t-butyl cyanide, acetone cyano) (Drin etc.) at 20
- organic solvents eg, tetrahydrofuran
- Hydrolysis reactions are also known and include, for example, organic solvents (eg, tetrahydrofuran, 2-methoxethyl ether, dimethyloxetane, acetonitrile, 1,4-dioxane, acetone, hexamethylphosphoramide, dimethylimidazolidinone, N , N-dimethylformamide, N, N-dimethylacetamide, N-methylpyrrolidone, dimethylsulfoxide, 1,3-dimethyl-3,4,5,6-tetrahydro-2-pyrimidinone, or a mixed solvent of any ratio thereof
- peracids eg, hydrogen peroxide, t-butyl hydroperoxide, perbenzoic acid, m-chloroperbenzoic acid, etc., or an aqueous solution thereof
- peracids eg, hydrogen peroxide, t-butyl hydroperoxide, perbenzoic acid, m-chloroperbenz
- step (B) The compound of formula (I) shown in step (B) is subjected to a one-carbon enrichment reaction to give (2R) -2-propyloctane nitrile, which is further hydrolyzed to give (2R) -2-propyl
- the reaction to convert to heptane amide is formed as an intermediate, and is hydrolyzed in the reaction system without isolation of (2R) -2-propyloctanenitrile
- the reaction may be performed in one step (one pot), or the intermediate may be isolated and subjected to hydrolysis reaction in two steps, but the one-step (one pot) method is preferred.
- step (B) is carried out in one pot by subjecting the compound represented by the formula (I) to a cyanation reaction, followed by a hydrolysis reaction without isolating the resulting (2R) -2-propyloctanenitrile. It is performed by attaching to. That is, the compound represented by the formula (I) is reacted with a cyanating reagent in an organic solvent at 20 to 80 ° C, and then a peracid is added to the reaction system, and the mixture is reacted at a temperature of 0 to 50 ° C. Perform the hydrolysis reaction.
- step (B) (1 S) — 1-propylheptyl p-toluenesulfonate is subjected to a one-carbon enrichment reaction to convert it to (2R) — 2-propyloctane-tolyl. It is preferable to use dimethyl sulfoxide as a solvent and sodium cyanide as a cyanating reagent.
- step (B) (1S) —1-propylheptyl methanesulfonate is subjected to a one-carbon enrichment reaction to convert it to (2R) —2-propyloctanenitrile. It is preferable to use dimethylsulfoxide and lithium cyanide as the cyanating reagent.
- step (B) in the reaction of hydrolyzing (2R) -2-propyloctane nitrile to convert it to (2R) -2-propyloctaneamide, dimethyl sulfoxide is used as the organic solvent and 35% as the peracid. It is preferable to use hydrogen oxide water.
- step (B) if necessary to obtain high-purity (2R) -2-propyloctaneamide, purification can be performed by recrystallization.
- the recrystallization solvent include water, ethanol, methanol, n-propanol, isopropanol ⁇ ⁇ , ⁇ -ptano-1, ⁇ / acetonitrile, acetone, dimethoxetane, tetrahydrofuran, ethyl acetate, isopropyl acetate, toluene, ⁇ —Heptane, getyl carbonate, t-butyl methyl ether, acetic acid or May be a mixed solvent of two or more of these at an arbitrary ratio, and is preferably a mixed solvent of water and acetonitrile.
- the conversion reaction of (2R) -2-propyloctaneamide to (2R) -2-propylotatanic acid is carried out by subjecting (2R) -2-propyloctanamide to a hydrolysis reaction.
- This hydrolysis reaction is known, for example, acid [mineral acid (for example, hydrochloric acid, sulfuric acid, hydrobromic acid, nitric acid, phosphoric acid, or a mixture thereof), organic acid (for example, formic acid, acetic acid, propionic acid) , Trifluoroacetic acid, trichloroacetic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesnolefonic acid, J) -treensnolefonic acid, camphorsnolefonic acid, oxalic acid, citric acid or a mixture thereof), Or a mixture thereof or an aqueous solution thereof] at 20 to 160 ° C.
- mineral acid for example, hydrochloric
- step (C) of hydrolyzing (2R) -2-propyloctaneamide and converting it to (2R) -2-propyloctanoic acid a mixture of 6 mo 1ZL hydrochloric acid and acetic acid may be used as the acid. preferable.
- an unsaturated organometallic reagent for example, magnesium bromide, magnesium bromide, magnesium ethinium chloride, magnesium bromide, Magnesium, etc.
- an unsaturated organometallic reagent for example, magnesium bromide, magnesium bromide, magnesium ethinium chloride, magnesium bromide, Magnesium, etc.
- (2S) -2-hexyloxysilane is used as a starting material in place of (2R) -2-hexyloxylan.
- high-purity (2S) -2-propyloctanoic acid can be produced.
- the intermediates and products obtained by the present invention can be isolated by known isolation and purification means, for example, concentration, concentration under reduced pressure, distillation, reduced pressure distillation, solvent extraction, crystallization, recrystallization, phase transfer, chromatography and the like. It can be purified.
- the symbol .. ⁇ indicates that it is connected to the other side of the paper (that is, ⁇ -configuration), and ⁇ indicates that it is closer to the paper.
- y represents ⁇ —configuration, js—configuration, or a mixture of any ratio thereof
- ⁇ represents one configuration and any ratio of one configuration. Indicates a mixture.
- the present invention is intended to convert (2R) -2-propyloctanoic acid of high optical purity, which is useful as a medicament for preventing and / or treating neurodegenerative diseases caused by astrocyte dysfunction, to (2R) -2
- the present invention provides a method for obtaining a compound by hydrolysis from xyloxylan via crystalline (2R) -2-propylotatanamide.
- the method of the present invention is a method suitable for industrial production in which (2R) -2-propyloctanoic acid can be efficiently obtained with a reduced number of steps and without a dangerous reaction as compared with the conventional method. is there.
- the solvent used for NMR measurement is all cyclochlorozolem.
- Example 2 Preparation of (2R) -2-propyloctaneamide Under an argon atmosphere, sodium cyanide (470 mg) was added to a solution of the compound prepared in Example 1 (1.5 g) in dimethyl sulfoxide (9.6 mL), and the mixture was stirred at 40 ° C. for 10 hours.
- Example 4 The compound (500 mg) produced in Example 4 having an optical purity of 96.0% ee was dissolved by heating in acetonitrile (4.5 mL) and water (5.5 mL), allowed to cool, and the precipitated crystals were filtered. I took it. The crystals were washed with water to give the title compound (430 mg). Optical purity: 99.5% ee (confirmed by HPLC)
- Example 6 Production of (2R) -I-2-propyloctanoic acid
- Example 6 The same operations as in Example 1 ⁇ Example 2 ⁇ Example 6 were performed using (2S) —2-hexyloxysilane instead of (2R) -1-hexyloxysilane, and the following physical property values were obtained.
- the compound of the present invention was obtained.
- the present invention hydrolyzes (2R) -2-hexyloxylan via crystalline (2R) -2-propylotatanamide to prevent neurodegenerative diseases caused by astrocyte dysfunction and / or Another object of the present invention is to provide a method for obtaining (2R) -2-propyloctanoic acid having high optical purity, which is useful as a therapeutic drug.
- the production method of the present invention is a method suitable for industrial production in which (2R) -2-propyloctanoic acid can be efficiently obtained with a smaller number of steps than the conventional method without causing a dangerous reaction.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/560,176 US7589221B2 (en) | 2003-06-10 | 2004-06-09 | Process for producing (2R)-2-propyloctanoic acid and intermediate therefor |
| JP2005506969A JP4742868B2 (ja) | 2003-06-10 | 2004-06-09 | (2r)−2−プロピルオクタン酸の製造方法、その中間体 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003164485 | 2003-06-10 | ||
| JP2003-164485 | 2003-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004110972A1 true WO2004110972A1 (ja) | 2004-12-23 |
Family
ID=33549187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2004/008387 Ceased WO2004110972A1 (ja) | 2003-06-10 | 2004-06-09 | (2r)−2−プロピルオクタン酸の製造方法、その中間体 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US7589221B2 (ja) |
| JP (1) | JP4742868B2 (ja) |
| WO (1) | WO2004110972A1 (ja) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007000970A1 (ja) | 2005-06-27 | 2007-01-04 | Ono Pharmaceutical Co., Ltd. | 疼痛治療剤 |
| WO2007046347A1 (ja) | 2005-10-18 | 2007-04-26 | Ono Pharmaceutical Co., Ltd. | 筋萎縮性側索硬化症患者の運動神経保護用医薬 |
| WO2007072902A1 (ja) | 2005-12-22 | 2007-06-28 | Ono Pharmaceutical Co., Ltd. | 急性期脳梗塞治療剤 |
| EP2072047A1 (en) | 2005-03-15 | 2009-06-24 | Ono Pharmaceutical CO., LTD. | Therapeutic agent for opthalmic disease |
| JP2011530608A (ja) * | 2008-08-15 | 2011-12-22 | ザ プロクター アンド ギャンブル カンパニー | 消費者製品における感覚剤として有用なシクロヘキサン誘導体の合成 |
| CN102675166A (zh) * | 2012-05-11 | 2012-09-19 | 山东齐都药业有限公司 | 用于制备2-丙基庚酸的新中间体、其制备方法及2-丙基庚酸的制备方法 |
| US8273916B2 (en) | 2004-04-28 | 2012-09-25 | Ono Pharmaceutical Co., Ltd. | Crystal comprising (2R)-2-propyloctanoic acid and amine |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01275541A (ja) * | 1988-04-28 | 1989-11-06 | Nippon Mining Co Ltd | 光学活性を有する4−アルカノール類の製造方法 |
| JPH07316092A (ja) * | 1993-06-01 | 1995-12-05 | Ono Pharmaceut Co Ltd | ペンタン酸誘導体、その製造方法およびそれらを含有する薬剤 |
| WO1999058513A1 (en) * | 1998-05-12 | 1999-11-18 | Ono Pharmaceutical Co., Ltd. | Novel intermediates and processes for the preparation of optically active octanoic acid derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3864387A (en) * | 1973-05-21 | 1975-02-04 | Upjohn Co | 5-Oxa phenyl-and phenoxy-substituted prostaglandin F{HD 1{301 {0 {B analogs |
| US20030083231A1 (en) * | 1998-11-24 | 2003-05-01 | Ahlem Clarence N. | Blood cell deficiency treatment method |
-
2004
- 2004-06-09 US US10/560,176 patent/US7589221B2/en not_active Expired - Fee Related
- 2004-06-09 WO PCT/JP2004/008387 patent/WO2004110972A1/ja not_active Ceased
- 2004-06-09 JP JP2005506969A patent/JP4742868B2/ja not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01275541A (ja) * | 1988-04-28 | 1989-11-06 | Nippon Mining Co Ltd | 光学活性を有する4−アルカノール類の製造方法 |
| JPH07316092A (ja) * | 1993-06-01 | 1995-12-05 | Ono Pharmaceut Co Ltd | ペンタン酸誘導体、その製造方法およびそれらを含有する薬剤 |
| WO1999058513A1 (en) * | 1998-05-12 | 1999-11-18 | Ono Pharmaceutical Co., Ltd. | Novel intermediates and processes for the preparation of optically active octanoic acid derivatives |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8273916B2 (en) | 2004-04-28 | 2012-09-25 | Ono Pharmaceutical Co., Ltd. | Crystal comprising (2R)-2-propyloctanoic acid and amine |
| EP2072047A1 (en) | 2005-03-15 | 2009-06-24 | Ono Pharmaceutical CO., LTD. | Therapeutic agent for opthalmic disease |
| EP2266559A1 (en) | 2005-03-15 | 2010-12-29 | Ono Pharmaceutical Co., Ltd. | Therapeutic agent for ophthalmic disease |
| WO2007000970A1 (ja) | 2005-06-27 | 2007-01-04 | Ono Pharmaceutical Co., Ltd. | 疼痛治療剤 |
| EP2465499A2 (en) | 2005-06-27 | 2012-06-20 | Ono Pharmaceutical Co., Ltd. | Therapeutic agent for treating pain |
| US8975298B2 (en) * | 2005-06-27 | 2015-03-10 | Ono Pharmaceutical Co., Ltd. | Therapeutic agent for pain |
| WO2007046347A1 (ja) | 2005-10-18 | 2007-04-26 | Ono Pharmaceutical Co., Ltd. | 筋萎縮性側索硬化症患者の運動神経保護用医薬 |
| WO2007072902A1 (ja) | 2005-12-22 | 2007-06-28 | Ono Pharmaceutical Co., Ltd. | 急性期脳梗塞治療剤 |
| JP2011530608A (ja) * | 2008-08-15 | 2011-12-22 | ザ プロクター アンド ギャンブル カンパニー | 消費者製品における感覚剤として有用なシクロヘキサン誘導体の合成 |
| CN102675166A (zh) * | 2012-05-11 | 2012-09-19 | 山东齐都药业有限公司 | 用于制备2-丙基庚酸的新中间体、其制备方法及2-丙基庚酸的制备方法 |
| CN102675166B (zh) * | 2012-05-11 | 2014-03-26 | 山东齐都药业有限公司 | 用于制备2-丙基庚酸的新中间体、其制备方法及2-丙基庚酸的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2004110972A1 (ja) | 2006-07-20 |
| US7589221B2 (en) | 2009-09-15 |
| JP4742868B2 (ja) | 2011-08-10 |
| US20060135802A1 (en) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102630226A (zh) | 恩替卡韦的合成方法及其中间体化合物 | |
| WO2007105729A1 (ja) | シクロプロピルアミド化合物の製造方法 | |
| US8912345B2 (en) | Method for preparing optically pure (−)-clausenamide compound | |
| WO2004110972A1 (ja) | (2r)−2−プロピルオクタン酸の製造方法、その中間体 | |
| WO2003042180A9 (en) | Process for producing optically active oxoheptenoic acid ester | |
| JP5301676B2 (ja) | (3s,4s)−4−((r)−2−(ベンジルオキシ)トリデシル)−3−ヘキシル−2−オキセタノンの製造方法及びそれに用いられる新規な中間体 | |
| JP2001151724A (ja) | 光学活性な2,2,4−トリメチル−3−シクロヘキセンカルボン酸の製造方法 | |
| WO2003051852A1 (en) | Intermediate and process for producing optically active compound from the intermediate | |
| WO2014094511A1 (zh) | 一种制备曲前列尼尔的中间体、其制备方法以及通过其制备曲前列尼尔的方法 | |
| WO1996036603A1 (en) | Improved process for producing 4-hydroxy-2-pyrrolidone | |
| AU2005257483B2 (en) | Method for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2-hydroxymethyl cyclopropane | |
| KR100714197B1 (ko) | 보글리보스의 제조방법 | |
| JP3184345B2 (ja) | 5−クロロオキシインドールの製造方法 | |
| KR100743617B1 (ko) | 고광학순도를 갖는 키랄 3-히드록시 피롤리딘 및 그유도체를 제조하는 방법 | |
| JPS63190851A (ja) | 光学活性カルボン酸をつくる立体異性化方法 | |
| JP3823385B2 (ja) | 2,4,5−トリフルオロ−3−ヨ−ド安息香酸およびそのエステル類の製造方法 | |
| JP2005194243A (ja) | メントール誘導体およびその製造方法 | |
| CN110577974B (zh) | 手性3-羟基-1,2,3,6-四氢吡啶的合成方法 | |
| JPH04273835A (ja) | 光学活性アルコールの製造法 | |
| US6852867B2 (en) | Process for preparation of a benzofuran derivative | |
| KR100461571B1 (ko) | 고순도 (s)-1,2,4-부탄트리올의 제조방법 | |
| KR20120110682A (ko) | 수소화붕소나트륨을 이용한 (3S)-3-(tert-부톡시카르보닐)아미노-1-클로로-4-페닐-(2S)-부탄올의 제조방법 | |
| JP4560309B2 (ja) | 光学活性なアミノ酸誘導体の製造方法 | |
| CN103965130B (zh) | 一种帕立骨化醇中间体的制备方法 | |
| WO2004037815A1 (ja) | 光学活性n−(2,3−エポキシプロパンー1−イル)フタルイミドの製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2005506969 Country of ref document: JP |
|
| ENP | Entry into the national phase |
Ref document number: 2006135802 Country of ref document: US Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 10560176 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 10560176 Country of ref document: US |
|
| 122 | Ep: pct application non-entry in european phase |